Improvements in health care and lifestyle have led to an elevated lifespan and increased
focus on age-associated diseases, such as neurodegeneration, cardiovascular disease …

The receptor for advanced glycation endproducts (RAGE) is an ubiquitous, transmembrane,
immunoglobulin-like receptor that exists in multiple isoforms and binds to a diverse range of …

The receptor for advanced glycation end products (RAGE) is a central signaling molecule in
the innate immune system and is involved in the onset and sustainment of the inflammatory …

RAGE (receptor for advanced glycation end-products) is a multiligand receptor of the
immunoglobulin superfamily involved in inflammation, diabetes, atherosclerosis …

Nonenzymatic protein glycation results in the formation of advanced glycation end products
(AGEs) that are implicated in the pathology of diabetes, chronic inflammation, Alzheimer's …

The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor
involved in inflammatory processes and is associated with diabetic complications, tumor …

RAGE may be a biomarker and/or target for therapeutic intervention in chronic disease such
as diabetes, inflammation, neurodegeneration, and tumors. The RAGE binds multiple ligand …

Eur J Clin Invest 2010; 40 (8): 742–755 Abstract Background Advanced glycation end‐
products (AGEs) are increased in situations with hyperglycemia and oxidative stress such as …

Diabetes-induced hyperglycemia increases the extracellular concentration of methylglyoxal.
Methylglyoxal-derived hydroimidazolones (MG-H) form advanced glycation end products …

The multi-ligand Receptor for Advanced Glycation Endproducts (RAGE) is implicated in the
pathogenesis and progression of chronic diseases such as diabetes and …